Literature DB >> 10722543

Intrapulmonary arteriovenous shunting may be a universal phenomenon in patients with the superior cavopulmonary anastomosis: a radionuclide study.

J J Vettukattil1, Z Slavik, R K Lamb, J L Monro, B R Keeton, V T Tsang, A J Aldous, A Zivanovic, S Johns, V Lewington, A P Salmon.   

Abstract

OBJECTIVE: To evaluate the extent of intrapulmonary right to left shunting in children after bidirectional cavopulmonary anastomosis (BCPA).
DESIGN: Prospective study of patients who underwent BCPA in a single centre. PATIENTS: 17 patients with complex cyanotic congenital cardiac malformations who underwent BCPA at 1-45 months of age (median 21 months) were evaluated 15-64 months postoperatively (median 32 months). Five children between 1 and 10 years (median 5 years) with normal or surgically corrected intracardiac anatomy and peripheral pulmonary circulation who required V/Q scanning for other reasons were used as controls.
INTERVENTIONS: All patients underwent cardiac catheterisation to exclude angiographically demonstrable venovenous collaterals followed by pulmonary perfusion scanning using (99m)technetium ((99m)Tc) labelled albumen microspheres to quantify the intrapulmonary right to left shunt. MAIN OUTCOME MEASURE: Percentage of intrapulmonary right to left shunt.
RESULTS: The mean (SD) level of physiological right to left shunting found in the control group was 5.4 (2.3)%. All patients with BCPA showed the presence of a significantly higher level of intrapulmonary shunting (26.8 (16.9)%, p < 0.001). The degree of shunting was significantly increased in the subgroup of 11 patients with BCPA as the only source of pulmonary blood flow (34.9 (15.8)%), when compared to the six remaining patients with an additional source of pulmonary blood supply (12.0 (2.6)%, p < 0.001). There was a negative correlation between age at BCPA and the shunt percentage found in the patients with a competitive source of pulmonary blood flow (r = -0.63, p < 0. 01).
CONCLUSIONS: Intrapulmonary right to left shunting develops in all patients following BCPA. This may be caused by a sustained and inappropriate vasodilatation resulting from absence or decreased levels of a substance that inhibits pulmonary vasodilatation. Augmenting BCPA with an additional source of blood flow containing hepatic factor limits the degree of intrapulmonary arteriovenous shunting and may help provide successful longer term palliation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722543      PMCID: PMC1729376          DOI: 10.1136/heart.83.4.425

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

1.  A cure for pulmonary arteriovenous fistulas?

Authors:  W B Knight; R B Mee
Journal:  Ann Thorac Surg       Date:  1995-04       Impact factor: 4.330

2.  AHA president's letter.

Authors:  S C Smith
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

3.  Septal/free wall curvature ratio: a noninvasive index of pulmonary arterial pressure.

Authors:  S A Reisner; Z Azzam; M Halmann; D Rinkevich; S Sideman; W Markiewicz; R Beyar
Journal:  J Am Soc Echocardiogr       Date:  1994 Jan-Feb       Impact factor: 5.251

4.  Pulmonary blood supply in bidirectional cavopulmonary anastomosis with pulsatile pulmonary blood flow: quantitative analysis using radionuclide angiocardiography.

Authors:  O Reich; P Horváth; C Ruth; M Krejcír; J Skovránek
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

Review 5.  Mechanisms of gas exchange impairment in patients with liver cirrhosis.

Authors:  A G Agusti; J Roca; R Rodriguez-Roisin
Journal:  Clin Chest Med       Date:  1996-03       Impact factor: 2.878

6.  A rare cause of profound cyanosis after Kawashima modification of bidirectional cavopulmonary anastomosis.

Authors:  Z Slavik; R K Lamb; S A Webber; D J Delaney; A P Salmon
Journal:  Ann Thorac Surg       Date:  1995-08       Impact factor: 4.330

7.  Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome.

Authors:  G A Abrams; C C Jaffe; P B Hoffer; H J Binder; M B Fallon
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

8.  Pulmonary arteriovenous shunting in children with liver disease.

Authors:  T Barbé; J Losay; G Grimon; D Devictor; A Sardet; F Gauthier; D Houssin; O Bernard
Journal:  J Pediatr       Date:  1995-04       Impact factor: 4.406

9.  Resolution of severe intrapulmonary shunting after liver transplantation.

Authors:  S J Schwarzenberg; D K Freese; W E Regelmann; P F Gores; R J Boudreau; W D Payne
Journal:  Chest       Date:  1993-04       Impact factor: 9.410

10.  Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia.

Authors:  G T Stavri; I C Zachary; P A Baskerville; J F Martin; J D Erusalimsky
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

View more
  15 in total

1.  Pathogenesis of pulmonary arteriovenous malformations: role of hepatopulmonary interactions.

Authors:  J J Vettukattil
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

2.  Morphological studies of pulmonary arteriovenous shunting in a lamb model of superior cavopulmonary anastomosis.

Authors:  S M Bradley
Journal:  Pediatr Cardiol       Date:  2008-07       Impact factor: 1.655

Review 3.  Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications.

Authors:  Minoo N Kavarana; Jeffrey A Jones; Robert E Stroud; Scott M Bradley; John S Ikonomidis; Rupak Mukherjee
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-04-23

4.  Hepatic Vein Blood Increases Lung Microvascular Angiogenesis and Endothelial Cell Survival-Toward an Understanding of Univentricular Circulation.

Authors:  Andrew D Spearman; Ankan Gupta; Amy Y Pan; Emily I Gronseth; Karthikeyan Thirugnanam; Todd M Gudausky; Susan R Foerster; Ramani Ramchandran
Journal:  Semin Thorac Cardiovasc Surg       Date:  2020-05-07

5.  Pulmonary artery endothelial cell phenotypic alterations in a large animal model of pulmonary arteriovenous malformations after the Glenn shunt.

Authors:  Minoo N Kavarana; Rupak Mukherjee; Shaina R Eckhouse; William F Rawls; Christina Logdon; Robert E Stroud; Risha K Patel; Elizabeth K Nadeau; Francis G Spinale; Eric M Graham; Geoffrey A Forbus; Scott M Bradley; John S Ikonomidis; Jeffrey A Jones
Journal:  Ann Thorac Surg       Date:  2013-08-20       Impact factor: 4.330

6.  Morphological studies of pulmonary arteriovenous shunting in a lamb model of superior cavopulmonary anastomosis.

Authors:  David Michael McMullan; Vadiyala Mohan Reddy; William M Gottliebson; Norman H Silverman; Stanton B Perry; Frandics Chan; Frank Louis Hanley; Robert Kirk Riemer
Journal:  Pediatr Cardiol       Date:  2007-11-28       Impact factor: 1.655

7.  Diagnosis and management of pulmonary arteriovenous malformations.

Authors:  J Papagiannis; S Apostolopoulou; Ge Sarris; S Rammos
Journal:  Images Paediatr Cardiol       Date:  2002-01

Review 8.  Estimating intracardiac and extracardiac shunting in the setting of complex congenital heart disease.

Authors:  Ryan J Stark; Lara S Shekerdemian
Journal:  Ann Pediatr Cardiol       Date:  2013-07

9.  In Search of "Hepatic Factor": Lack of Evidence for ALK1 Ligands BMP9 and BMP10.

Authors:  Teresa L Capasso; Sara M Trucco; Morgan Hindes; Tristin Schwartze; Jamie L Bloch; Jacqueline Kreutzer; Stephen C Cook; Cynthia S Hinck; Davide Treggiari; Brian Feingold; Andrew P Hinck; Beth L Roman
Journal:  Am J Respir Crit Care Med       Date:  2021-01-15       Impact factor: 21.405

10.  Endostatin, an inhibitor of angiogenesis, decreases after bidirectional superior cavopulmonary anastamosis.

Authors:  Aida Field-Ridley; Ritva Heljasvaara; Taina Pihlajaniemi; Ian Adatia; Christine Sun; Roberta L Keller; Wen Hui Gong; Sanjeev Datar; Peter Oishi; Jeffrey R Fineman
Journal:  Pediatr Cardiol       Date:  2012-09-08       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.